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EFFECTS OF IRON AND ZINC SUPPLEMENTATION ON GROWTH 
AND MORBIDITY STATUS OF UNDERNOURISHED INFANTS 
(6-12 MONTHS OLD) FROM RURAL VILLAGES IN KELANTAN 
By 
YIMHIP SENG 
April 2001 
Chairman: Professor Khor Geok Lin, Ph.D. 
Faculty: Medicine and Health Sciences 
Stunting in children is a common form of undernutrition in developing countries. 
Deficiency of micronutrients including iron and zinc has been associated with growth 
faltering in young children. The aim of the study was to assess the effects of iron and 
zinc supplementation on the growth and morbidity status of undernourished infants 
from rural villages in the district ofKota Bharu, Kelantan. 
A six months randomised, double-blind, placebo-controlled study was conducted on 9S 
undernourished (weight-for-age Z score < -1.0 SD ofNCHS reference) infants aged 6-
12 months. The infants were divided into 5 groups, comprising 4 supplementation and 
a placebo groups: Group I-Fe (20 mg/week) + Zn (17 mg/week) with vitamins A (1700 
Jlg/week) and C (20 mg/week); Group II-Fe with vitamins A and C; Group III-Zn with 
vitamins A and C; Group IV-Fe + Zn only; and Group V-Placebo (plain syrup). 
Length, weight and circumferences of mid-upper arm (MUAC), head and chest were 
measured monthly. Morbidity status as indicated by symptoms including diarrhoea, 
fever, cough, running nose and vomiting was recorded by interviewing the mothers 
fortnightly. Information on feeding practices, use of complementary foods and their 
nutrient intake were also obtained from the mothers. 
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At the beginning of the study, there were no significant differences in the 
anthropometric indices among the infants in all the supplementation and placebo 
groups. At the end of the study, among the three groups that received vitamins A and 
C, Group I (Fe + Zn) and Group III (Zn) showed higher gain values in weight, length 
and MUAC than Group II (Fe). However, there were no significant differences in the 
gain values among these three groups. Comparing between Group I (Fe + Zn with 
vitamins A and C) and Group IV (Fe + Zn without vitamins A and C), there were no 
significant differences in the gain values for weight, length and MUAC. 
When comparing all· the four supplementation groups with the placebo group, it is 
found that Groups I, III and IV consistently ranked higher in the gain values for weight, 
length and MUAC than the placebo group. Group II showed lower gain value for 
weight than the placebo group. However, the differences in the gain values for all the 
anthropometric indices were not significant among all the five groups at the end of the 
study. 
All the four supplementation groups recorded significantly lower prevalence and 
shorter duration of !11IlI1ing nose and cough episodes compared with the placebo group. 
The mean prevalence and duration of fever occurrences in Group I and Group ill were 
significantly lower than in Group II and the placebo group. 
During the six months study, majority of the infants (>60%) were either breastfed and 
given infant formula with complementary foods or given infant formula with 
complementary foods, while about 16% ceased breastfeeding. Insufficient breast milk 
and children disliking breast milk were the main reasons for cessation of breast feeding. 
Solid foods including commercial cereals, rice and porridge were first introduced at the 
mean age of five months. Based on the 24-hour recall, intake of protein, calcium, iron, 
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thiamine, riboflavin and niacin were found to be below the RDA levels for Malaysians. 
The mean intake of calories was about one-third of the RDA level. However, intake of 
vitamins A and C were above the RDA level (excluding the supplements given). 
In general, weekly supplementation of zinc and iron was found to produce higher gain 
values in weight, length and MUAC of un demo uri shed infants than the placebo group, 
although the differences were not statistically significant. The gain in the 
anthropometric indices appeared to be better for groups that received zinc by itself or in 
combination with iron supplementation. Morbidity status of the supplementation 
groups was generally better than that of the placebo group. The supplementation 
groups showed significantly lower prevalence and duration of running nose, cough and 
fever occurrences compared to the placebo group. More studies are necessary to 
detennine the effectiveness of iron and zinc supplementation for periods longer than six 
months on the nutritional and health status ofundemourished infants. 
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Pertumbuhan terbantut di kalangan kanak-kanak merupakan masalah malpemakanan di 
ban yak negara membangun. Kekurangan mikronutrien termasuk ferum dan zink 
didapati mempunyai perkaitan dengan pertumbuhan terbantut dalam kanak-kanak. 
Objektif kajian ini ialah untuk mengkaji kesan suplementasi ferum dan zink ke atas 
pertumbuhan dan status morbiditi bayi-bayi yang mengalami malpemakanan dari 
kampung-kampung luar bandar di Daerah Kota Bharu, Kelantan. 
Satu kajian rawak, "double-blind", kawalan-plasebo selama enam bulan dijalankan ke 
atas 95 bayi yang mengalami malpemakanan (berat-ikut-umur Z skor < -1 .0 SD 
daripada rujukan NCHS) berumur 6-12 bulan. Bayi-bayi ini dibahagikan kepada 5 
kumpulan, dengan 4 kumpulan suplementasi dan 1 kumpulan plasebo: Kumpulan I-Fe 
(20 mglminggu) + Zn ( 1 7  mglminggu) dengan vitamin A (1700 Jlglminggu) dan vitamin 
C (20 mglminggu); Kumpulan II-Fe dengan vitamin A dan vitamin C; Kumpulan III-
Zn dengan vitamin A dan vitamin C; Kumpulan IV-Fe + Zn sahaja; dan Kumpulan V-
Plasebo ( sirup) 
vi 
Panjang, berat, lilitan lengan tengah atas (MUAC), dada dan kepala diukur sebulan 
sekali. Status morbiditi yang dieirikan sebagai simtom termasuk eirit-birit, demam, 
batuk, selsema, sesak nafas dan muntah direkodkan dua minggu sekali dengan 
menemubual ibu. Maklumat tentang penyusuan bayi, makanan tambahan dan 
pengambilan nutrien juga diperolehi semasa kajian dijalankan. 
Pada pennulaan kajian, tidak terdapat perbezaan yang signifikan dari segi indeks 
anthropometrik di antara kumpulan-kumpulan suplementasi dan plasebo. Pada akhir 
kajian, antara kumpulan-kumpulan yang menerima vitamin A dan C, Kumpulan I (Fe + 
Zn) dan Kumpulan III (Zn) menunjukkan pertambahan yang lebih dalam berat, panjang, 
dan MUAC berbanding Kumpulan II (Fe). Tetapi, tiada perbezaan signifikan dalam 
nilai pertambahan antara ketiga-tiga kumpulan ini. Dalam perbandingan antara 
Kumpulan I (Fe + Zn dengan vitamin A dan C) dengan Kumpulan IV (Fe + Zn sahaja), 
tiada perbezaan yang signifikan dalam pertambahan berat, panjang dan MUAC. 
Dalam perbandingan antara semua kumpulan suplementasi dengan kumpulan plasebo, 
Kumpulan I, III dan IV menunjukkan pertambahan nilai yang lebih dalam berat, panjang 
dan MUAC, berbanding kumpulan plasebo. Kumpulan II menunjukkan pertambahan 
berat yang lebih rendah berbanding dengan kumpulan plasebo. Tetapi, tiada perbezaan 
yang signifikan dalam nilai pertambahan untuk semua indeks anthropometrik antara 
kelima-lima kumpulan pada akhir kajian. 
Kesemua 4 kumpulan suplementasi menunjukkan penurunan prevalens dan jangka masa 
untuk selsema dan batuk berbanding dengan Kumpulan plasebo. Min prevalens dan 
jangka masa untuk demam dalam Kumpulan I dan III menunjukkan penurunan 
signifikan berbanding Kumpulan II dan Kumpulan Plasebo. 
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Semasa enam bulan kajian, kebanyakan daripada bayi-bayi (>60%) menerima samada 
penYUSUan ibu dan diberi susu formula dengan makanan tambahan atau diberi susu 
formula dengan makanan tambahan, manakala lebih kurang 16% sudah berhenti 
penyusuan ibu. Kekurangan susu ibu dan bayi tidak suka susu ibu adalah antara sebab 
berhenti penyusuan ibu. Makanan pejal termasuk bijirin komersil, nasi dan bubur 
pertama kali diberi kepada bayi pada min umur lima bulan. Berdasarkan "ingatan 24 
jam", pengambilan protein, kalsium, ferum, thiamin, riboflavin dan niasin didapati 
berada di bawah paras RDA untuk Malaysia. Pengambilan kalori adalah lebih-kurang 
satu-pertiga daripada paras RDA. Tetapi, pengambilan vitamin A dan C berada lebih 
daripada paras RDA (tidak termasuk suplemen yang diberikan). 
Umumnya, mingguan suplementasi dengan zink dan ferum menghasilkan pertambahan 
berat, panjang dan MUAC dalam bayi-bayi yang mengalami malpemakanan berbanding 
kumpulan plasebo, tetapi perbezaan adalah tidak signifikan secara statistik. 
Pertambahan indeks anthropometrik ini menampakkan nilai yang lebih baik dalam 
kumpulan yang menerima zink atau dengan ferum suplementasi. Status morbiditi dalam 
kumpulan suplementasi secara umumnya lebih baik berbanding kumpulan plasebo. 
Kumpulan suplementasi menunjuklcan penun:nan prevalens dan jangka masa bagi 
selsema, batuk dan demam berbanding kumpulan plasebo. Lebih banyak kajian 
diperlukan untuk menentukan kesan ferum dan zink suplementasi untuk jangka waktu 
yang lebih daripada enam bulan ke atas taraf pemakanan dan kesihatan bayi-bayi yang 
yang mengalami malpemakanan. 
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GLOSSARY OF TERMS 
Definitions used in the WHO Global Data Bank on Breastfeeding 
Exclusive breastfeeding refers to all children less than 2 years who are exclusively 
breast fed before the age of 4 months [<120 days]. This includes breast feeding 
from a wet nurse and feeding on expressed breast milk. However, it also includes 
children who were given vitamins, minerals, medicines, holy water, drops or syrups 
in addition to breast milk. 
Ever breastfed is defined as all children less than 2 years who were ever given 
breast milk at any time. 
Predominant breastfeeding is defined as all children less than 2 years who are 
given breast milk as the predominant source of nourishment before the age of 4 
months [<120 days]. This indicator includes children who were fed on breast milk 
(including breastfeeding from wet nurse and feeding on expressed breast milk), as 
well as given other liquids (such as water, glucose water and fruit juice) except 
other non-human milk and food-based fluids. 
Complementary feeding refers to children less than 2 years who were given breast 
milk and complementary foods including other non-human milk, solid or semi-solid 
foods before the age of 4 months [<120 days]. 
Bottle-feeding includes all children less than 2 years given any liquid or semi-solid 
food from a bottle with teat including expressed breast milk. 
(Source: WHO, 1996a) 
Anthropometric Indicators of Nutritional Status 
Underweight defined as weight-for-age below minus 2 SD from the United States 
National Center for Health Statistics (NCHS) median. 
Stunted defined as height-for-age below minus 2 SD from the NCHS median. 
Wasted defined as weight-for-height below minus 2 SD from the NCHS median. 
(Source: WHO, 1986) 
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CHAPTER ONE 
INTRODUCTION 
Background 
Nutritional deficiencies including micronutrient deficiency prevail as a significant 
public health problem in most developing countries. It is estimated that at least 
20% of the world population is at risk for micronutrient deficiency, primarily in 
developing regions (Trowbridge et aI., 1993). Among the micronutrients, iron, 
iodine, and vitamin A deficiencies are the most prevalent in the at risk groups, 
which include young children and women of childbearing age. 
Iron deficiency and anaemia affect more than 3.5 billion people in the developing 
countries (UNICEFIUNUIWHOIMI, 1999). The affected population groups in 
these countries are pregnant women (56%), school-age children (53%), non­
pregnant women (44%) and pre-school children (42%) (United Nations ACC/SCN, 
2000). As for iodine deficiency, globally about 740 million people are affected by 
goitre, and more than two billion (or over 38% of the population living in 130 
countries) are estimated to be at risk of iodine deficiency disorders (United Nations 
ACC/SCN, 2000). The magnitude of clinical and sub-clinical vitamin A deficiency 
among children under five years is estimated as three million children and 250 
million respectively (WHO, 1995a). 
Young children aged 6-24 months old are at greatest risk for micronutrient 
deficiency, including iron and zinc. Young children require iron and other 
micronutrients for rapid growth and normal body physiological needs that breast 
milk alone cannot meet. Low bioavailability- of iron, vitamin A and zinc in 
complementary foods, aggravates micronutrient deficiency condition in young 
children (Gibson, 1994). 
Micronutrient deficiencies alter physiological functions well before the clinically 
manifestation of the deficiency appears, and the true consequences of diet that is 
deficient in mUltiple micronutrients are often underestimated (Underwood, 1999). 
The consequential effects of micronutrient deficiencies include overall poor health, 
growth retardation, increased morbidity and mortality related to diarrhoea and 
respiratory diseases, psychomotor and learning disabilities, and reduced scholastic 
and work performance. 
The pnmary effects of iron and zinc deficiencies in young children can be 
profound. Iron deficiency decreases physical capacity and growth, impairs motor 
and mental development and scholastic achievement (Aukett et aI., 1986; Lozoff et 
aI., 1987; Idjradinata and Pollitt, 1993). Iron supplementation has been reported to 
decrease stunting rate among anaemic pre-school children in Indonesia (Angeles et 
aI., 1993). 
The impact of zinc deficiency on human health has received increasingly more 
recognition world-wide. Zinc deficiency has been postulated to be as common as 
iron deficiency in the developing region owing to the nature of the staple diets that 
are predominantly plant-based and intakes of animal tissues are low (Gibson and 
Ferguson, 1998). Growth retardation and increased morbidity in young children 
have been shown to be associated with zinc deficiency in several studies (Chen 
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et ai., 1985; Smit-Vanderkooy and Gibson, 1987; Cavan et ai., 1993a). Zinc 
supplementation trials have shown to reduce the incidence, duration and severity of 
diarrhoea in Indian children (Sazawal et aI., 1995; 1996; 1997). 
In Malaysia, protein-energy malnutrition and micronutrient deficiency particularly 
iron and iodine in children still persist as a public health concern (Khor, 1997). 
Based on the Malaysian National Surveillance System in 1995, underweight 
(weight-for-age < -2.0 SD) among young children aged below five year was 
reported as 20.7% (Ministry of Health Malaysia, 1996). Meanwhile, the prevalence 
of stunting of infants in rural communities has been reported as 13.8% in boys and 
10.8% in girls (Khor and Tee, 1997). 
The prevalence of anaemia among young children between six and 24 months has 
been reported between 15% and 60% amongst different rural community groups 
(Tee et aI., 1998). Whereby, a goitre prevalence of about 46% was found in 
population aged 15 years and above in an inland Than community in Sarawak (Yap, 
1985), and in Kelantan, a goitre rate of 37% in the same age group has been 
reported (Mafauzy et aI., 1993). 
Statement of Problem 
Growth retardation prevails at moderate to high levels among children especially 
from low socio-economic families in developing countries. Approximately 43% of 
the children under five years of age in these countries are stunted (De Onis et aI., 
1993), as defined by height-for-age less than -2.0 SD of the WHOINCHS reference 
median (WHO, 1986). Low dietary intake particularly energy and protein is 
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a major factor associated with poor linear growth. Low dietary intake often 
includes inadequacy in micronutrient intake as well (Allen, 1 994). 
In the early years of life, growth in length is on one part influenced by nutritional 
and environmental factors, such as poor diets and high infection rates, which in tum 
are the basic cause of stunting (Lei et aI., 1 999). Marginal zinc status is likely in 
children in developing countries, generally as a result of low quality diets that are 
often low in iron and zinc but high in fibre and phytates (Bates et al., 1993; 
Ferguson et al., 1 993). Iron deficiency anaemia and reduced growth rate among 
pre-school children are two important nutrition-related problems in the developing 
countries (United Nations ACe/SCN, 1987; De Maeyer, 1 989). Therefore, iron and 
zinc deficiencies have an important role in the overall growth and health status of 
young children, and should be of great concern to health authorities. 
A number of community trials testing the effects of zinc supplementation on the 
growth of the children have been conducted world-wide with contradictory results. 
Positive effects of zinc supplementation on growth were documented in tHO major 
studies in the 1 970's involving infants from low-economic families in the United 
States (Walravens and Hambidge, 1 976), and school-aged boys and girls from Iran 
(Ronaghy et al., 1 974). 
Studies in the late 1 980's and early 1 990's on school-aged boys with low height­
for-age in Canada (Gibson et aI., 1 989), infants from low-economic in France 
(Walravens et aI., 1 992), children recovering from malnutrition in Bangladesh 
(Khanum et aI., 1 988) and in Chile (Schlesinger et aI., 1 992) also showed 
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beneficial effects of zinc supplementation on growth. Growth of stunted infants 
was shown to improve with zinc supplementation in two recent studies, in 
Guatemala (Rivera et aI., 1 998) and Ethiopia (Umeta et aI., 2000). 
However, there were other studies that did not fmd positive cffects of zinc on 
growth. These include studies involving pre-school and school-aged children from 
the United States (Hambidge et aI., 1 979), school-aged children in Guatemala 
(Cavan et a!., 1 993b), and pre-school children with suspected zinc deficiency in The 
Gambia (Bates et a!., 1 993) and Mexico (Rosado et a!., 1 997). 
Iron deficiency has been shown to impair motor and mental development in young 
children (Lozoff et aI., 1 99 1 ;  Idjradinata et aI., 1 993). Programmes such as mass 
supplementation and food fortification of iron have been advocated in many 
countries to combat iron deficiency (yip, 1 994). Iron supplementation have been 
shown to promote growth and reduced infectious disease morbidity in children 
(Chwang et aI., 1 988; Angeles et aI., 1 993). 
As for studies that investigated the combined effects of iron and zinc, both iron and 
zinc deficiency were found to cause impaired immune response (Dallman, 1 987; 
Keen and Gershwin, 1 990). In Mexico, Rosado and colleagues ( 1997) found a 
significant reduction in morbidity related to diarrhoea in a group of Mexican pre­
school children who received zinc and iron supplements. They also found a 
reduction in morbidity related to respiratory disease but this was not statistically 
significant from that for the placebo group. 
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